Fat Reduction Market in Europe to Soar Despite Economic Downturn
WALTHAM, Mass., July 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the fat reduction device market will experience the highest growth of all body contouring devices in Europe
through 2013. MRG's European...
Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
SAN DIEGO, June 18, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that the company is scheduled to present at the Piper Jaffray Fourth Annual Europe
Conference on June 23, 2009 at 9:30 a.m. British Summer Time (4:30 am Eastern Time, 1:30 a.m. Pacifi...
Alexza's Corporate Presentation to be Webcast at the Piper Jaffray Fourth Annual Europe Conference
MOUNTAIN VIEW, Calif., June 11 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that its corporate presentation will be webcast live during the Piper Jaffray Fourth Annual Europe
Conference on Tuesday, June 23, 2009 at 9:00 a.m. London Time. The presentatio...
"Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America"
MONTREAL, June 9 /PRNewswire/ - Europe
Cosmetiques and Probiox announced today that both companies entered into a licensing and collaboration agreement with respect to oxidative stress profiling. Under this agreement, Europe
Cosmetiques acquires an exclusive license for Canada, United States and M...
First 100 Patients Treated in Europe with the MitraClip(R) System for Percutaneous Mitral Repair
Use of the MitraClip(R) Therapy Continues to Expand in Europe
MENLO PARK, Calif., May 14 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip(R...
Health ingredients Europe Shortlisted for AEO's Best Trade Show Over 2000m2 Award
MAARSSEN, Netherlands, May 7 /PRNewswire/ -- Health ingredients Europe
(HiE), the leading nutraceutical and functional food & beverage trade show, has been shortlisted for the Association of Event Organisers (AEO) Best Trade Show Over 2000m2 Award, announced UBM International Media (UBM-IM).
Pixantrone Now Available in Europe on a Named-Patient Basis
Cell Therapeutics and IDIS Partner to Accelerate Patient Access to Pixantrone through Program
SEATTLE, May 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced that pixantrone is now available on a named-patient basis in Europe. Pixantrone will be s...
New P.E. Drug Approved In Europe While Premature Ejaculation Cure Remains Out of Reach to American Men
Demand for one of the leading, anti-premature ejaculation formulas is expected to soar after regulatory approvals for the first medicine for premature ejaculation are granted outside of the United States.
Los Angeles, CA (PRWEB) April 3, 2009 -- American men who eagerly...
Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software
Varian's VariSeed(TM) 8.0 Offers Advantages in Simplifying Dose Planning and Identifying Seed Positions, according to Clinicians
CHARLOTTESVILLE, Va., March 31 /PRNewswire-FirstCall/ -- Prostate cancer patients have begun receiving brachytherapy using new treatment planning software that enab...
New data on cancer survival in Europe show more patients are cured
New data and analyses from a long-running study of cancer survival in Europe
have shown that the number of people actually cured of cancer rather than just surviving for at least five years after diagnosis is rising steadily.
A special issue of the European Journal of Cancer  containing ...
Better health and prosperity in Europe via improved clinical research
Improved patient-oriented research in Europe
will benefit European citizens and the European medical industry and facilitate the transfer of scientific discoveries from the laboratory bench to the bedside. For Europe
and for the rest of the world this effort will be of great importance for the qua...
NeuroFocus Expands Into the UK and Europe Through Acquisition of Neuroco
World's Leading Neurological Testing Company Purchases Leading UK Firm In The Fast Growing Field of Brainwave-Based Market Research
BERKELEY, Calif., March 12 /PRNewswire/ -- NeuroFocus, the world's leading company in the rapidly-expanding field of neuromarketing, announced that it has conclu...
Immune-based drug approved in Europe for pediatric cancer patients
HOUSTON ? The European Commission, which oversees legislation and regulation for the European Union, has approved a therapy for pediatric patients with non-metastatic, resectable osteosarcoma, a type of bone cancer. The approval is based on clinical studies led by researchers at The University of ...
IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
First New Agent Approved to Treat Osteosarcoma in More Than 20 Years
IRVINE, Calif., March 9 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that the European Commission has formally granted a Centralized marketing authorization for MEPACT(R) (mifamurtide, L-MTP...
A Broad-Spectrum Antibiotic with Activity Against MRSA and Pseudomonas Aeruginosa Would Earn a Higher Patient Share in the U.S. than in Europe for the Treatment of Hospital-Acquired Pneumonia
Merck's Drug Will Remain Decision Resources Gold Standard Through 2017, According to a New Report from Decision Resources
WALTHAM, Mass., March 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a b...
An Oral Disease-Modifying Drug for Relapsing-Remitting Multiple Sclerosis Would Earn High Patient Shares in Both Europe and the United States
Tysabri is Decision Resources' Gold Standard Through 2017 for Relapsing-Remitting Multiple Sclerosis, According to a New Report from Decision Resources
WALTHAM, Mass., Feb. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and heal...
A Biologic Drug Superior to Spiriva in Reducing COPD-Related Exacerbations Would Earn a Higher Patient Share in Europe Than in the U.S.
Spiriva Will Remain the Gold Standard Treatment Through 2017, According to a New Report from Decision Resources.
WALTHAM, Mass., Jan. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that ...
Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
UCB's Keppra XR Will Become the Gold Standard Adjunctive Treatment for Partial-Onset Epilepsy by 2012, According to a New Report from Decision Resources
WALTHAM, Mass., Jan. 7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical...
Hard To Treat Diseases (HTDS) Completes E Europe Merger
CLEARWATER, FL, Jan. 5 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com Further to the company's various merger updates where amongst other things the company addressed several targeted merger candidates, the company is pleased to announce that it has finalized its bila...
Comparable data on maternal and infant in Europe available for the first time
Promoting healthy pregnancy and safe childbirth is a goal of all European health care systems. Despite progress in recent decades, mothers and their babies are still very much at risk during the perinatal period, which covers pregnancy, delivery, and the postpartum.
The European Perinatal Heal...
Ansell Healthcare Europe Lands 2008 Frost & Sullivan Customer Service Leadership Award for its Ansell Guardian(SM) Safety Program
BRUSSELS, November 19 /PRNewswire/ --
- Ansell Guardian(SM) Enables Companies to Make the Right Decisions for
Increasing Both Safety and Productivity
In recognition of Ansell Healthcare's performance in the European market
for hand protection solutions Frost & Sullivan, a globa...
China Healthcare Acquisition Corp Agrees to Terminate Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
PASADENA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- China Healthcare
Acquisition Corp (Amex: CHM , CHMU, CHMW) ("CHM") announced today that China
Healthcare Acquisition Corp ("CHM") and Teambest International, Ltd. and
Madame Wang Lahua (collectively, "Seller") have mutually agreed, effective...
Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
Dr. Henry JM Barnett, London, Ontario, receives the Karolinska Stroke Award for Excellence in Stroke Research. The prize amounts to 100,000 SEK. The laureate will receive the prize from the President of Karolinska Institutet Harriet Wallberg-Henriksson during the Karolinska Stroke Update meeting i...
UCLH to Discuss Using Business Process Management to Meet Government Referral-To-Treatment Mandate at IRM BPM Europe 2008
Lombardi Customer University College London Hospitals NHS Trust Presents Case Study for Patient Tracking System at London Conference
London, UK (PRWEB) September 25, 2008 -- Lombardi, a leader in http://www.lombardi.com/ [business process management (BPM) __title__ busi...
Sigma Breakthrough Technologies, Inc. (SBTI) Is Expanding Its Service Offering for Global Clients by Announcing the Public Listing of SBTI Europe GmbH
SAN MARCOS, Texas, Aug. 27 /PRNewswire/ -- SBTI, a global management
consulting firm, announced today the public listing as an operating company
called SBTI Europe
GmbH to be located in Basel, Switzerland. With a growing
demand for global services, SBTI is strengthening its position in Europe
China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
PASADENA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- China Healthcare
Acquisition Corp (Amex: CHM , CHMU, CHMW) ("CHM") and Europe
Environment Holding Pte, Ltd. ("EAHE") announced today that CHM and the
owner of EAHE signed a definitive acquisition agreement for CHM to acquire
Boca Raton Based Plastic Surgeon Introduces Revolutionary New Adjustable Breast Implant to Europe and Asia
BOCA RATON, Fla., June 25 /PRNewswire/ -- Dr. Hilton Becker M.D.,
F.A.C.S., F.R.C.S. of Boca Raton, Florida, who has been working on creating
breast implants for the last 20 years, has created his most effective
implant yet -- the Spectra Adjustable Gel Implant which is 90 percent
Vital Images Europe Surpasses 1,000 Licenses
Industry Leader Continues Strong Growth in European Market
THE HAGUE, The Netherlands, June 24 /PRNewswire-FirstCall/ -- Vital
Images, Inc. (Nasdaq: VTAL ), a worldwide leader of enterprise-wide advanced
visualization and analysis solutions, has surpassed the milestone of 1,000
National Rehabilitation Hospital Team Calls Work of US Army's Europe Regional Medical Command Impressive
WASHINGTON, June 20 /PRNewswire-USNewswire/ -- A team of medical
professionals from the National Rehabilitation Hospital is calling the U.S.
Army's rehab services in Germany impressive. The NRH team has been in
Germany since last weekend to work with the US Army's Europe
ATS Medical to Participate at the Piper Jaffray Europe Conference
MINNEAPOLIS, June 18 /PRNewswire-FirstCall/ -- ATS Medical, Inc.
(Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac
surgery products, today announced that it will participate at the Piper
Conference in London, England on Wednesday, June 25, 2008.
Stroke More Prevalent in U.S. Than in Europe
Poor Americans fare worse; risks, health-care system cited as factors
FRIDAY, Feb. 22 (HealthDay News) -- Americans have a significantly higher prevalence of stroke than their European counterparts, possibly because of additional risk factors and barriers to health care faced by those ...
Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
LA JOLLA, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Immunosyn
Corporation (OTC Bulletin Board: IMYN) announced today that the first phase
of a formal "Proof of Concept Trial" for the biopharmaceutical SF-1019 has
been successfully completed in Europe
for treatment of Diabetic Ulcers.
Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
Consistent Continuation of Globalisation Path and Extension of Product Offerings
DUSSELDORF, Germany, December 21 /PRNewswire-FirstCall/ -- Gerresheimer
AG is consistently continuing its strategy of globalisation and extension
of product offerings in the pharma a...
Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
PARIS and LAUSANNE, Switzerland, Oct. 31 /PRNewswire/ -- Ipsen
(Euronext: FR0010259150; IPN) and Debiopharm Group (Debiopharm), a global
independent biopharmaceutical development specialist in oncology and
serious medical conditions today announced the extension of their
agreement, whereby Ips...
Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
- Presentation to highlight milestones including phase III development of 'GI-friendly' NSAIDs for mild to moderate pain -
PALO ALTO, Calif., Oct. 5 /PRNewswire/ --
What: Horizon Therapeutics, Inc. is pleased to announce that George Tidmarsh, M.D., Ph.D., c...
Stille and Enova Form Strategic Partnership to Introduce World's Brightest LED Cordless Surgical Headlights Into Europe and Japan
ST. PAUL, Minn., Sept. 24 /PRNewswire/ -- Enova Medical Technologies
and Stille AB (listed at First North Sweden) are pleased to announce that
they have entered into a strategic marketing and distribution partnership.
Beginning in the 4th quarter of 2007, Stille will market Enova's
Cancer control in Europe works; now it is time to extend it to poorer countries
Barcelona, Spain: Only a few years ago cancer was considered to be a disease of westernised, developed countries, but now the burden is increasingly falling on less developed countries, a leading epidemiologist told ECCO 14, the European Cancer Conference, today (Monday 24 September). Professor Pe...
Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
SEATTLE, July 29 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it was notified by the European Medicines Agency ("EMEA") that pixantrone is eligible to be submitted for a Marketing Authorization Application ("MAA") through...
World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe
TOLOCHENAZ, Switzerland, July 14 /PRNewswire-FirstCall/ --
- CE Mark Approval for Medtronic's Reclaim(R) DBS Therapy for Treatment
of Chronic, Severe Obsessive-Compulsive Disorder
Medtronic today announced that Reclaim(R) Deep Brain Stimulation (DBS)
Therapy has received CE (Conf...
Combating heart disease and stroke: Planning for a healthier Europe
Cardiovascular diseases (CVD) are the main cause of early death and disability in Europe, accounting each year for the loss of more than 2 million lives and costing the EU economy an estimated 192 billion. Top level stakeholders and EU and national policymakers are meeting in Brussels to assess cu...